Dr. Peter Bryant-Greenwood is the president and chief executive officer at Healix Pathology. He has 25 years of leadership experience in molecular diagnostics and personalized medicine. After graduating in Medicine from the John A. Burns School of Medicine at the University of Hawaii, Dr. Bryant-Greenwood completed residencies and fellowships at the Laboratory of Pathology (National Cancer Institute) and the Center for Biologics, Evaluation and Research (U.S. Food and Drug Administration). He has served as Director of Molecular Diagnostics and Biorepository, Director of Comprehensive Genetics and GI Pathology, and Director of Pathology Services at the Queen's Medical Center in Hawaii and spent 13 years as Executive Vice Chair of the Department of Pathology at John A. Burns School of Medicine. Dr. Bryant-Greenwood also served as Director of Molecular Genomics and Medical Director of Advanced Diagnostic Laboratories at National Jewish Health, an integrated group of laboratories specializing in CRO and esoteric referral testing. Dr. Bryant-Greenwood is a Fellow of the College of American Pathologists and a Fellow of the American College of Healthcare Executives. He holds a Master of Business Administration in Medical Services Management and Marketing from the Johns Hopkins University.
Undergraduate: 1992, Georgetown University, School of Foreign Service
Science, Technology and International Affairs
The John A. Burns School of Medicine, University of Hawaii
The Johns Hopkins University
MBA in Medical Services Management and Marketing, 2004